<p>Adage Capital Partners GP L.L.C. 在最近提交给证券交易委员会的 13F 报告中表示，在第二季度其在丹纳赫公司（NYSE:DHR - 免费报告）的持股增加了 2.2%。该机构投资者在此期间购买了 21,469 股后，持有该综合企业的 1,002,895 股股票。截至其最近一次向证券交易委员会提交的报告，Adage Capital Partners GP L.L.C. 持有丹纳赫 0.14% 的股份，价值 198,112,000 美元。</p>
<ul>
<li>一个隐藏在明面上的 AI 投资机会：约翰逊控制公司分析</li>
</ul>
<p>其他一些对冲基金也买卖了 DHR 的股票。White Pine Capital LLC 在第二季度将其在丹纳赫的持股增加了 1.4%。White Pine Capital LLC 目前持有 3,494 股该综合企业的股票，价值 690,000 美元，此前在上个季度又购买了 49 股。Boyd Watterson Asset Management LLC OH 在第二季度将其在丹纳赫的持股增加了 2.1%。Boyd Watterson Asset Management LLC OH 目前持有 2,524 股该综合企业的股票，价值 499,000 美元，此前在此期间又收购了 51 股。Worth Financial Advisory Group LLC 在第二季度将其在丹纳赫的持股增加了 4.6%。Worth Financial Advisory Group LLC 目前持有 1,195 股该综合企业的股票，价值 236,000 美元，此前在上个季度又购买了 53 股。Bruce G. Allen Investments LLC 在第二季度将其在丹纳赫的持股增加了 13.1%。Bruce G. Allen Investments LLC 目前持有 467 股该综合企业的股票，价值 92,000 美元，此前在此期间又购买了 54 股。最后，Texas Bank &amp; Trust Co 在第二季度将其在丹纳赫的持股增加了 1.6%。Texas Bank &amp; Trust Co 目前持有 3,567 股该综合企业的股票，价值 705,000 美元，此前在此期间又购买了 55 股。机构投资者和对冲基金持有该公司 79.05% 的股票。</p>
<h2>丹纳赫的内部活动</h2>
<p>在其他消息中，SVP Brian W. Ellis 于 11 月 12 日星期三出售了 21,776 股公司的股票。该股票以平均价格 219.23 美元出售，总价值为 4,773,952.48 美元。出售完成后，该高级副总裁直接持有公司 14,553 股股票，价值 3,190,454.19 美元。此次交易使其持股减少了 59.94%。该交易在向证券交易委员会的报告中披露，具体信息可通过此链接获取。此外，SVP Georgeann Couchara 于 11 月 10 日星期一出售了 5,174 股公司的股票。该股票以平均价格 210.42 美元出售，总价值为 1,088,713.08 美元。交易完成后，该高级副总裁直接持有公司 2,625 股股票，价值约 552,352.50 美元。此次交易使其持股减少了 66.34%。有关此次出售的更多细节可在官方 SEC 披露中找到。内部人士在过去 90 天内共出售了价值 6,609,663 美元的 30,248 股公司股票。公司内部人士持有该公司 11.10% 的股票。</p>
<h2>分析师评级变动</h2>
<ul>
<li>3 只提供强大价值和稳定性的股票</li>
</ul>
<p>DHR 一直是多份研究报告的主题。加拿大皇家银行在 9 月 2 日星期二的报告中将丹纳赫的目标价格设定为 241.00 美元。Rothschild &amp; Co Redburn 在 10 月 8 日星期三的研究报告中重申了 “中性” 评级，并将丹纳赫的目标价格下调至 220.00 美元（之前为 245.00 美元）。美国银行在 9 月 22 日星期一的研究报告中将丹纳赫的目标价格从 230.00 美元下调至 220.00 美元，并对该公司给予 “买入” 评级。摩根士丹利在 12 月 1 日星期一的研究报告中开始覆盖丹纳赫的股票。他们给予 “增持” 评级，并设定 270.00 美元的目标价格。最后，Weiss Ratings 在 10 月 8 日星期三的报告中重申了对丹纳赫的 “持有（c-）” 评级。21 位投资分析师对该股票给予 “买入” 评级，4 位给予 “持有” 评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “适度买入”，平均目标价格为 246.79 美元。</p>
<p><strong>查看我们最新的 DHR 股票报告</strong></p>
<h2>丹纳赫价格表现</h2>
<ul>
<li>安捷伦科技因 “永恒化学品” 打击而蓬勃发展</li>
</ul>
<p>NYSE:DHR 周五开盘价为 226.70 美元。该公司的债务与股本比率为 0.33，流动比率为 1.52，速动比率为 1.10。该公司的 50 日移动平均价格为 218.51 美元，200 日移动平均价格为 205.67 美元。丹纳赫公司的 1 年低点为 171.00 美元，1 年高点为 258.23 美元。该公司的市值为 1,601.3 亿美元，市盈率为 46.74，市盈率增长比率为 4.51，贝塔值为 0.89。</p>
<p>丹纳赫（NYSE:DHR - 获取免费报告）最近于 10 月 20 日星期一发布了季度财报。该综合企业报告季度每股收益为 1.89 美元，超出市场共识预期的 1.72 美元，超出幅度为 0.17 美元。丹纳赫的净利润率为 14.44%，股本回报率为 10.92%。该公司季度收入为 60.5 亿美元，而分析师预期为 60 亿美元。去年同期，该企业每股收益为 1.71 美元。该公司的收入同比增长 4.4%。股票研究分析师预测丹纳赫公司本年度每股收益将达到 7.63 美元。</p>
<h2>丹纳赫分红公告</h2>
<p>该公司最近还宣布了一项季度分红，将于 1 月 30 日星期五支付。12 月 26 日星期五的股东将获得每股 0.32 美元的分红。除息日期为 12 月 26 日星期五。这相当于每年 1.28 美元的分红，分红收益率为 0.6%。丹纳赫的分红支付比率（DPR）为 26.39%。</p>
<h2>丹纳赫公司简介</h2>
<p>（免费报告）</p>
<p>丹纳赫公司在全球范围内设计、制造和销售专业、医疗、工业和商业产品及服务。生物技术部门提供生物处理技术、耗材和服务，以推进、加速和整合治疗药物的开发和制造；细胞系和细胞培养基开发服务；用于制造的细胞培养基、工艺液体和缓冲液；色谱树脂、过滤技术、无菌灌装；一次性硬件和耗材及服务，如完整制造套件的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；试剂、膜和服务；以及医疗过滤解决方案。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们认为比丹纳赫更好的股票</li>
<li>什么是支撑位？</li>
<li>Synopsys 看到乐观转变，因为 Ansys 整合推动增长</li>
<li>10 只最佳航空公司股票推荐</li>
<li>你能给自己最好的节日礼物是什么？Costco 股票</li>
<li>精通纪律：克服交易中的情绪挑战</li>
<li>为什么 Zscaler 股票在经历 30% 的抛售后可能准备反弹</li>
</ul>
<p><strong>想看看其他对 DHR 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取丹纳赫公司（NYSE:DHR - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在丹纳赫吗？</h2>
<p>在考虑丹纳赫之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而丹纳赫并不在名单上。</p>
<p>虽然丹纳赫目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

丹纳赫

<p>Adage Capital Partners GP L.L.C. 在第二季度将其在丹纳赫公司的股份增加了 2.2%，目前持有 1,002,895 股，价值 1.981 亿美元。内部人士的销售包括高级副总裁 Brian W. Ellis 和高级副总裁 Georgeann Couchara，共计出售了 30,248 股。分析师的评级不一，普遍持有适度买入的共识，平均目标价为 246.79 美元。丹纳赫在周五的开盘价为 226.70 美元</p>

<p>Adage Capital Partners GP L.L.C. increased its stake in Danaher Corporation (NYSE:DHR - Free Report) by 2.2% in the second quarter, according to its most recent 13F filing with the Securities &amp; Exchange Commission. The institutional investor owned 1,002,895 shares of the conglomerate's stock after purchasing an additional 21,469 shares during the period. Adage Capital Partners GP L.L.C. owned 0.14% of Danaher worth $198,112,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p>
<div class="lb-trans"><p>Adage Capital Partners GP L.L.C. 在最近提交给证券交易委员会的 13F 报告中表示，在第二季度其在丹纳赫公司（NYSE:DHR - 免费报告）的持股增加了 2.2%。该机构投资者在此期间购买了 21,469 股后，持有该综合企业的 1,002,895 股股票。截至其最近一次向证券交易委员会提交的报告，Adage Capital Partners GP L.L.C. 持有丹纳赫 0.14% 的股份，价值 198,112,000 美元。</p>
</div><ul>
<li>An AI Play Hiding in Plain Sight: A Look at Johnson Controls</li>
</ul>
<div class="lb-trans"><ul>
<li>一个隐藏在明面上的 AI 投资机会：约翰逊控制公司分析</li>
</ul>
</div><p>A number of other hedge funds have also bought and sold shares of DHR. White Pine Capital LLC grew its holdings in shares of Danaher by 1.4% during the second quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate's stock valued at $690,000 after buying an additional 49 shares during the last quarter. Boyd Watterson Asset Management LLC OH lifted its position in Danaher by 2.1% during the 2nd quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate's stock worth $499,000 after acquiring an additional 51 shares during the period. Worth Financial Advisory Group LLC grew its stake in Danaher by 4.6% during the 2nd quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate's stock valued at $236,000 after purchasing an additional 53 shares during the last quarter. Bruce G. Allen Investments LLC increased its holdings in shares of Danaher by 13.1% in the second quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate's stock valued at $92,000 after purchasing an additional 54 shares during the period. Finally, Texas Bank &amp; Trust Co increased its holdings in shares of Danaher by 1.6% in the second quarter. Texas Bank &amp; Trust Co now owns 3,567 shares of the conglomerate's stock valued at $705,000 after purchasing an additional 55 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.</p>
<div class="lb-trans"><p>其他一些对冲基金也买卖了 DHR 的股票。White Pine Capital LLC 在第二季度将其在丹纳赫的持股增加了 1.4%。White Pine Capital LLC 目前持有 3,494 股该综合企业的股票，价值 690,000 美元，此前在上个季度又购买了 49 股。Boyd Watterson Asset Management LLC OH 在第二季度将其在丹纳赫的持股增加了 2.1%。Boyd Watterson Asset Management LLC OH 目前持有 2,524 股该综合企业的股票，价值 499,000 美元，此前在此期间又收购了 51 股。Worth Financial Advisory Group LLC 在第二季度将其在丹纳赫的持股增加了 4.6%。Worth Financial Advisory Group LLC 目前持有 1,195 股该综合企业的股票，价值 236,000 美元，此前在上个季度又购买了 53 股。Bruce G. Allen Investments LLC 在第二季度将其在丹纳赫的持股增加了 13.1%。Bruce G. Allen Investments LLC 目前持有 467 股该综合企业的股票，价值 92,000 美元，此前在此期间又购买了 54 股。最后，Texas Bank &amp; Trust Co 在第二季度将其在丹纳赫的持股增加了 1.6%。Texas Bank &amp; Trust Co 目前持有 3,567 股该综合企业的股票，价值 705,000 美元，此前在此期间又购买了 55 股。机构投资者和对冲基金持有该公司 79.05% 的股票。</p>
</div><h2>Insider Activity at Danaher</h2>
<div class="lb-trans"><h2>丹纳赫的内部活动</h2>
</div><p>In other news, SVP Brian W. Ellis sold 21,776 shares of the business's stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the sale, the senior vice president directly owned 14,553 shares in the company, valued at $3,190,454.19. The trade was a 59.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this link. Also, SVP Georgeann Couchara sold 5,174 shares of the company's stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $210.42, for a total value of $1,088,713.08. Following the transaction, the senior vice president directly owned 2,625 shares of the company's stock, valued at approximately $552,352.50. The trade was a 66.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 30,248 shares of company stock worth $6,609,663 in the last 90 days. Corporate insiders own 11.10% of the company's stock.</p>
<div class="lb-trans"><p>在其他消息中，SVP Brian W. Ellis 于 11 月 12 日星期三出售了 21,776 股公司的股票。该股票以平均价格 219.23 美元出售，总价值为 4,773,952.48 美元。出售完成后，该高级副总裁直接持有公司 14,553 股股票，价值 3,190,454.19 美元。此次交易使其持股减少了 59.94%。该交易在向证券交易委员会的报告中披露，具体信息可通过此链接获取。此外，SVP Georgeann Couchara 于 11 月 10 日星期一出售了 5,174 股公司的股票。该股票以平均价格 210.42 美元出售，总价值为 1,088,713.08 美元。交易完成后，该高级副总裁直接持有公司 2,625 股股票，价值约 552,352.50 美元。此次交易使其持股减少了 66.34%。有关此次出售的更多细节可在官方 SEC 披露中找到。内部人士在过去 90 天内共出售了价值 6,609,663 美元的 30,248 股公司股票。公司内部人士持有该公司 11.10% 的股票。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><ul>
<li>3 Stocks Offering Strong Value and Stability</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只提供强大价值和稳定性的股票</li>
</ul>
</div><p>DHR has been the subject of a number of research reports. Royal Bank Of Canada set a $241.00 target price on Danaher in a report on Tuesday, September 2nd. Rothschild &amp; Co Redburn reissued a &#34;neutral&#34; rating and set a $220.00 price target (down from $245.00) on shares of Danaher in a research report on Wednesday, October 8th. Bank of America decreased their price objective on shares of Danaher from $230.00 to $220.00 and set a &#34;buy&#34; rating for the company in a research note on Monday, September 22nd. Morgan Stanley began coverage on shares of Danaher in a research note on Monday, December 1st. They issued an &#34;overweight&#34; rating and a $270.00 price objective on the stock. Finally, Weiss Ratings reissued a &#34;hold (c-)&#34; rating on shares of Danaher in a report on Wednesday, October 8th. Twenty-one investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of &#34;Moderate Buy&#34; and an average target price of $246.79.</p>
<div class="lb-trans"><p>DHR 一直是多份研究报告的主题。加拿大皇家银行在 9 月 2 日星期二的报告中将丹纳赫的目标价格设定为 241.00 美元。Rothschild &amp; Co Redburn 在 10 月 8 日星期三的研究报告中重申了 “中性” 评级，并将丹纳赫的目标价格下调至 220.00 美元（之前为 245.00 美元）。美国银行在 9 月 22 日星期一的研究报告中将丹纳赫的目标价格从 230.00 美元下调至 220.00 美元，并对该公司给予 “买入” 评级。摩根士丹利在 12 月 1 日星期一的研究报告中开始覆盖丹纳赫的股票。他们给予 “增持” 评级，并设定 270.00 美元的目标价格。最后，Weiss Ratings 在 10 月 8 日星期三的报告中重申了对丹纳赫的 “持有（c-）” 评级。21 位投资分析师对该股票给予 “买入” 评级，4 位给予 “持有” 评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “适度买入”，平均目标价格为 246.79 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on DHR</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 DHR 股票报告</strong></p>
</div><h2>Danaher Price Performance</h2>
<div class="lb-trans"><h2>丹纳赫价格表现</h2>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷伦科技因 “永恒化学品” 打击而蓬勃发展</li>
</ul>
</div><p>NYSE:DHR opened at $226.70 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The company has a 50 day moving average price of $218.51 and a 200-day moving average price of $205.67. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23. The firm has a market cap of $160.13 billion, a price-to-earnings ratio of 46.74, a price-to-earnings-growth ratio of 4.51 and a beta of 0.89.</p>
<div class="lb-trans"><p>NYSE:DHR 周五开盘价为 226.70 美元。该公司的债务与股本比率为 0.33，流动比率为 1.52，速动比率为 1.10。该公司的 50 日移动平均价格为 218.51 美元，200 日移动平均价格为 205.67 美元。丹纳赫公司的 1 年低点为 171.00 美元，1 年高点为 258.23 美元。该公司的市值为 1,601.3 亿美元，市盈率为 46.74，市盈率增长比率为 4.51，贝塔值为 0.89。</p>
</div><p>Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter last year, the business earned $1.71 earnings per share. The firm's revenue was up 4.4% on a year-over-year basis. Equities research analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.</p>
<div class="lb-trans"><p>丹纳赫（NYSE:DHR - 获取免费报告）最近于 10 月 20 日星期一发布了季度财报。该综合企业报告季度每股收益为 1.89 美元，超出市场共识预期的 1.72 美元，超出幅度为 0.17 美元。丹纳赫的净利润率为 14.44%，股本回报率为 10.92%。该公司季度收入为 60.5 亿美元，而分析师预期为 60 亿美元。去年同期，该企业每股收益为 1.71 美元。该公司的收入同比增长 4.4%。股票研究分析师预测丹纳赫公司本年度每股收益将达到 7.63 美元。</p>
</div><h2>Danaher Dividend Announcement</h2>
<div class="lb-trans"><h2>丹纳赫分红公告</h2>
</div><p>The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a dividend of $0.32 per share. The ex-dividend date is Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher's dividend payout ratio (DPR) is 26.39%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 1 月 30 日星期五支付。12 月 26 日星期五的股东将获得每股 0.32 美元的分红。除息日期为 12 月 26 日星期五。这相当于每年 1.28 美元的分红，分红收益率为 0.6%。丹纳赫的分红支付比率（DPR）为 26.39%。</p>
</div><h2>Danaher Profile</h2>
<div class="lb-trans"><h2>丹纳赫公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.</p>
<div class="lb-trans"><p>丹纳赫公司在全球范围内设计、制造和销售专业、医疗、工业和商业产品及服务。生物技术部门提供生物处理技术、耗材和服务，以推进、加速和整合治疗药物的开发和制造；细胞系和细胞培养基开发服务；用于制造的细胞培养基、工艺液体和缓冲液；色谱树脂、过滤技术、无菌灌装；一次性硬件和耗材及服务，如完整制造套件的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；试剂、膜和服务；以及医疗过滤解决方案。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Danaher</li>
<li>What is a support level?</li>
<li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li>
<li>10 Best Airline Stocks to Buy</li>
<li>The Best Holiday Present You Can Give Yourself? Costco Stock</li>
<li>Mastering Discipline: Overcoming Emotional Challenges In Trading</li>
<li>Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比丹纳赫更好的股票</li>
<li>什么是支撑位？</li>
<li>Synopsys 看到乐观转变，因为 Ansys 整合推动增长</li>
<li>10 只最佳航空公司股票推荐</li>
<li>你能给自己最好的节日礼物是什么？Costco 股票</li>
<li>精通纪律：克服交易中的情绪挑战</li>
<li>为什么 Zscaler 股票在经历 30% 的抛售后可能准备反弹</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding DHR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 DHR 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取丹纳赫公司（NYSE:DHR - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=DHR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Danaher Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在丹纳赫吗？</h2>
</div><p>Before you consider Danaher, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑丹纳赫之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而丹纳赫并不在名单上。</p>
</div><p>While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然丹纳赫目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Adage Capital Partners GP L.L.C. 增加了其在丹纳赫公司 $DHR 的持股比例